ArticleTherapeutic innovation & regulatory science2025
Advancing Global Harmonization: Implementing Global Dose Form Attributes for Medicinal Products Identification.
Article in Therapeutic innovation & regulatory science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global pharmaceutical market includes a wide range of medicinal products, which makes it difficult to achieve consistent identification and classification across different regions. To address this, the International Organization for Standardization (ISO) developed five standards that together create a framework for the Identification of Medicinal Products (IDMP). Implementing the ISO IDMP standards globally necessitates collaboration to ensure consistent data. As part of these efforts, investigations were conducted to explore the feasibility of introducing global dose form attributes, which aim to standardize dose forms worldwide. These characteristics, defined by the European Directorate for the Quality of Medicines (EDQM), include the administrable basic dose form, administration method, intended site, and release characteristics. The global dose form attributes were successfully applied to data from nine countries, representing six dose form terminologies or lists, and were successfully assigned to over 99% of medicinal products. The process of assigning global dose form attributes was improved by mapping local dose form terminologies to global dose form attributes. The results from these studies were used to develop business rules for assigning the global dose form attributes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.